60 likes | 233 Views
Bharat Book Bureau provides the report, on “Pipeline Insight on Biosimilar (Insulin) Competitive Analysis Market 2015 ” Report analyzes that Insulin and Insulin Biosimilars holds a future scope and potential in the market. It highlights the market trends, regulatory requirements for US and EU and key domestic players. https://www.bharatbook.com/healthcare-market-research-reports-732714/biosimilar-insulin-competitive-landscape-pipeline-analysis.html
E N D
Pipeline Insight on Biosimilar (Insulin) • Competitive Analysis Market 2015
Summary • “Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2015” discusses the global insulin biosimilar industry. Report analyzes that Insulin and Insulin Biosimilars holds a future scope and potential in the market. It highlights the market trends, regulatory requirements for US and EU and key domestic players. • Report provides an insight on Insulin Biosimilars that are under development for Type 1 and Type 2 Diabetes with an insight on the Epidemiology of the disease. It provides detailed information on the 11 Insulin Biosimilar that are in pipeline. • It analyses Insulin Biosimilar industry and discusses the key market trends, major players, market assessment of 6 marketed insulin and the types of insulin with the length activity available in market. W : www.bharatbook.com , T : +91 22 27810772, 27810773, E : info@bharatbook.com
Scope • -Coverage of global insulin biosimilar under development across the globe • -Sales forecast for marketed insulin from 2015 to 2017 • -Detailed information on product description and related stage of development, the mode of therapy, mechanism of action, development partner and technology information. • -The report discusses the biosimilar regulatory landscape of various markets including developed markets of the US and EU • -Report analyses the types of insulin under development with respect to their market share and length of activity W : www.bharatbook.com , T : +91 22 27810772, 27810773, E : info@bharatbook.com
Reasons to buy • -The insulin biosimilar report covers complete Pipeline intelligence and understanding over therapeutics development for insulin market. • -Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • -Identify and understand important and diverse types of insulin under development • -Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline • -Devise corrective measures for pipeline projects by understanding the insulin biosimilar pipeline in-depth • -Identifying the upcoming leaders in the insulin biosimilar market in the coming year W : www.bharatbook.com , T : +91 22 27810772, 27810773, E : info@bharatbook.com
Table of Contents • Executive Summary • Biosimilar • History of Insulin and Insulin Biosimilar Development • Regulatory Pathways in US and EU • Illustration of the Originator and Biosimilar Development • Major Indication • Epidemology • Complications Associated with Diabetes • Diagnosis of Diabetes W : www.bharatbook.com , T : +91 22 27810772, 27810773, E : info@bharatbook.com
To view the full Executive Summary and Table of Contents, please visit: Pipeline Insight on Biosimilar (Insulin) Competitive Analysis Market 2015 Contact Us:-Call India: +91-22-27810772/73Email id : info@bharatbook.comWebsite : www.bharatbook.comOur Blog : https://www.bharatbook.com/blog/ W : www.bharatbook.com , T : +91 22 27810772, 27810773, E : info@bharatbook.com